Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
17/06/2026 11:28
BRIEF-Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate June 17 (Reuters) - Giant Biogene Holding Co Ltd 2367.HK:
RECEIVES CHINA MEDICAL DEVICE REGISTRATION FOR CROSS-LINKED RECOMBINANT COLLAGEN IMPLANT
CERTIFICATE ISSUED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Further company coverage: 2367.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan